According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM) is $0.31 M. In 2022 the company made a revenue of $1.77 M a decrease over the years 2021 revenue that were of $2.96 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.31 M | -82.28% |
2022 | $1.77 M | -40.2% |
2021 | $2.96 M | 182.19% |
2020 | $1.05 M | -76.46% |
2019 | $4.46 M | -46.8% |
2018 | $8.38 M | 109.49% |
2017 | $4 M | 19.96% |
2016 | $3.33 M | 31.43% |
2015 | $2.53 M | -41.23% |
2014 | $4.32 M | 0.09% |
2013 | $4.31 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |